ChemInform Abstract: Highly Enantioselective Mukaiyama Aldol Reactions Catalyzed by a Chiral Oxazaborolidinium Ion: Total Synthesis of (-)-Inthomycin C.
Department of Chemistry, Sungkyunkwan University, Suwon, 440-746, Korea. Organic Letters
(Impact Factor: 6.36).
10/2010; 12(22):5088-91. DOI: 10.1021/ol102234k
A cationic oxazaborolidinium-catalyzed asymmetric Mukaiyama aldol reaction of (1-methoxy-2-methyl-propenyloxy)-trimethylsilane with various aldehydes including α,β-disubstituted acroleins has been developed in high yields and enantioselectivities. The synthetic utility of this methodology was demonstrated in the first short synthesis of naturally occurring inthomycin C in high enantiopurity.
Available from: ocean.kisti.re.kr
[Show abstract] [Hide abstract]
ABSTRACT: Tamiflu, a neuraminidase inhibitor, is an antiviral medica-tion used to treat influenza virus in patients who have had symptoms for less than 2 days. The current key starting material for the production of Tamiflu is (-)-shikimic acid (1). 1 However, limited availability of 1 from natural Chinese star anise has led to the development of synthetic pathways to increase the supply of shikimic acid. 2 Besides its indus-trial uses, (-)-shikimic acid is a pivotal intermediate in the biogenetic synthesis pathway of a variety of aromatic natural products in microorganisms and plants known as the shikimate pathway. 3 In 1983, Masamune and co-workers achieved the first enantiospecific synthesis of (-)-shikimic acid 4 based on the asymmetric Diels-Alder reaction. Since then, substantial syn-thetic activity has been directed toward (-)-shikimic acid. 5 In 2000, Ogasawara and co-workers reported the synthesis of (-)-shikimic acid from lipase-resolved tricyclic alcohols employing a palladium mediated elimination reaction as the key step. 6 Furthermore, an efficient synthesis of (-)-shikimic acid from D-ribose was accomplished by Vankar et al. in 2009. 7 In conjunction with our interest in enantioselective Diels-Alder reactions with furans, we have found that the Diels-Alder reaction of furans with cationic chiral oxazaborolidinium catalyst 2 provides 7-oxabicyclo[2.2.1]hept-5-enes with high endo-selectivity and excellent enantioselectivity (Scheme 1). 8 In this paper, we report a method of efficient asymmetric synthesis of (-)-shikimic acid (1) from a chiral Diels-Alder adduct 3 between furan and acrylate. Chiral oxazaborolidinium salts (2; Scheme 1) work as powerful Lewis acids and have proven to be effective catalysts for various enantioselective Diels-Alder, 9 cyanosilylation 10a,b , Michael addition 10c , 1,3-dipolar cycloaddition, 11a three com-ponent coupling 11b and Mukayama aldol 11c reactions. With the readily available catalyst 2, the Diels-Alder reaction of furan and 2,2,2-trifluoroethyl acrylate at −78 o C provided chiral adduct 3 in 95% yield with a high endo/exo ratio (91/9) and in more than 99% ee 12 (endo). After chromatographic separation of the exo isomer, enantiomerically pure endo 3 was subjected to furan ring-opening with various bases. However, ring opened alcohol 5a was obtained in very low yield (Scheme 2). Conversion of the 2,2,2-trifluoroethyl ester to an ethyl ester with weakly basic ethanolic solvent followed by ring-opening with LiHMDS gave enantiomerically enriched diene 5b in 75% overall yield from 3. To introduce the diol with the correct stereochemistry, the free hydroxyl group in 5b was protected with a bulky TBDPS group to afford 6 in 88% yield. Catalytic dihydroxy-lation of 6 provided the desired diol 7 in 80% yield with complete stereoselectivity. 13 Desilylation of 7 afforded ethyl shikimate (8a) in 90% yield. Additionally, treatment of allylic alcohol 5b with osmium tetroxide afforded triol 8 in 70% yield with good stereoselectivity (8a/8b=7/1). Finally, saponification of 8a following a reported pro-cedure furnished (-)-shikimic acid (1) in 97% yield. Identity This paper is dedicated to Professor Eun Lee on the occasion of his ho-nourable retirement. Figure 1. Structure of (-)-Shikimic acid (1) and Tamiflu. Scheme 1. Highly enantioselective Diels-Alder reaction catalyzed by oxazaborolidinium salt 2. Communications to the Editor of the synthetic material was fully established through com-parisons of the 1 H-and 13 C-NMR spectra and specific rota-tions with literature data, = 180.0 (c 1.3, H 2 O), (> 99% ee). [lit. 14 = 179.7 (c 4, H 2 O)]. In summary, the total synthesis of (-)-shikimic acid was accomplished in 43.9% overall yield (via the TBDPS ether) or 42.5% overall yield (via the allylic alcohol) from com-mercially available furan and 2,2,2-trifluoroethyl acrylate. Acknowledgments.
Bulletin- Korean Chemical Society 08/2011; 32(spc8). DOI:10.5012/bkcs.2011.32.8.2885 · 0.80 Impact Factor
[Show abstract] [Hide abstract]
ABSTRACT: The first total synthesis of oxazolomycin A, a structurally novel oxazole polyene γ-lactam/β-lactone antibiotic, is described. Key features include the stereocontrolled construction of the right-hand heterocyclic core by taking advantage of an In(III)-catalyzed Conia-ene type cyclization and the asymmetric synthesis of the left-hand segment starting with a Cinchona alkaloid-catalyzed cyclocondensation of an aldehyde with an acid chloride.
Organic Letters 09/2011; 13(19):5398-401. DOI:10.1021/ol202306d · 6.36 Impact Factor
[Show abstract] [Hide abstract]
ABSTRACT: A catalytic synthetic route to highly functionalized chiral cyclopropane derivatives was developed by Michael-initiated cyclopropanation of α-substituted acroleins with aryl- and alkyl diazoacetates. In the presence of chiral (S)-oxazaborolidinium cation 1b as a catalyst, the reaction proceeded in high yield (up to 93%) with high to excellent diastereoselectivity (up to 98% de) and enantioselectivity (up to 95% ee).
Journal of the American Chemical Society 11/2011; 133(51):20708-11. DOI:10.1021/ja209270e · 12.11 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.